App-Quantinova.ai

Procoagulatory Changes in Patients with Chronic Lower Limb Ischemia

K. Komissarov - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

FVIII

Prognostic Model for Predicting the Risk of Symptomatic Venous Thromboembolism in Children and Adolescents with Lymphoma

D. Evstratov - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Protein tyrosine phosphatase PTPN22 modulates platelet function and thrombosis

J. Qiao - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

L-Tyrosine

Pulmonary thrombosis promotes sever flu in mice exposed to cigarette smoke.

T. Kaminski - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Dex-HEMA

Quality of life after a first venous thrombosis in elderly

H. Wang - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Rapid Detection of Exposure to Direct Oral Anticoagulants (DOACs): A Qualitative Urinary Dipstick Point-of-Care Assay

M. Marchetti - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Evithrom

Rate of recurrent venous thromboembolism in infants with unprovoked venous thromboembolism

H. Whitworth - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Real World Data of Pediatric Thromboembolic Disease by the International Pediatric Thrombosis Network

C. van Ommen - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Real World use of Apixaban for the Prevention and Treatment of Thrombosis in Children with Cardiac and Complex Disease

C. Vanderpluym - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

apixaban

Real- world effectiveness and safety of rivaroxaban in patients with non-valvular atrial fibrillation and venous thromboembolism in Saudi Arabia

F. Alqahtani - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

rivaroxaban

Recurrence risk of a first systemic lupus erythematosus-associated venous thromboembolism: a retrospective cohort study

S. Bhoelan - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Recurrent arterial thrombosis in haemophilia A

L. Stanciakova - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

FVIII

Recurrent venous-thromboembolism: association with thrombin generation and D-Dimer

E. Biguzzi - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Evithrom

Red-light exposure reduces venous thrombosis in mice

E. Andraska - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

releasate

Renal function at enrollment but not change over time is associated with arterial thrombotic events in patients positive for lupus anticoagulant

M. Colling - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Results in Patients with Heparin Induced Thrombocytopenia or Vaccine Induced Thrombocytopenia with Thrombosis Confirm the Unsuitability of Using APTT Ratio to Monitor Argatroban Therapy

S. Platton - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Argatroban

Retrieval rate and complications of inferior vena cava filters placed during acute venous thromboembolism.

D. Santagata - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Risk and impact of anticoagulation-associated abnormal menstrual bleeding in women of reproductive age with venous thromboembolism – the TEAM-VTE study

C. De Jong - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Risk factors for bleeding after recent medical hospitalization: The Medical Inpatient Thrombosis and Hemostasis Study (MITH)

M. Gergi - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Risk Factors of Venous Thromboembolism among Elderly Patients with Acute Myeloid Leukemia by Race in the United States

A. Faiz - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Filters

7277 Abstracts